A Cost Analysis of Interstim Therapy

NCT00200031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2008-07-28

No results posted yet for this study

Summary

A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.

Conditions

  • Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency)

Interventions

DEVICE

Interstim therapy

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Sherif Aboseif, MD · Kaiser Permanente

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200031 on ClinicalTrials.gov